VolitionRx Limited (NYSEAMERICAN:VNRX) Short Interest Update

VolitionRx Limited (NYSEAMERICAN:VNRX) was the target of a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 570,500 shares, a drop of 20.3% from the December 15th total of 715,700 shares. Based on an average trading volume of 262,100 shares, the days-to-cover ratio is currently 2.2 days.

VolitionRx Trading Down 2.2 %

NYSEAMERICAN VNRX traded down $0.01 during trading hours on Friday, reaching $0.63. The company’s stock had a trading volume of 90,541 shares, compared to its average volume of 91,895. VolitionRx has a 1 year low of $0.43 and a 1 year high of $1.23. The stock has a market cap of $39.68 million, a PE ratio of -1.12 and a beta of 1.59.

About VolitionRx

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes.